Not Finding What You're Looking For?
Fifth Annual Pediatric CP Course: Technological Advancements in the Management of Cerebral Palsy
In-Person Learning
Crain’s Features Shirley Ryan AbilityLab’s ‘Sustainability Guru’ and Eco-Friendly Efforts
In tandem with Earth Day 2024, Crain’s Chicago Business highlighted Shirley Ryan AbilityLab’s ongoing sustainability efforts in an article based on a recent interview with the hospital’s executive director, Facilities, Lamar Davis.
News
Shirley Ryan AbilityLab Attending Physician Featured in Nationally Syndicated Article on New Rapid Blood Test to Assess Mild TBI
A news article on a new rapid blood test that can determine if someone has sustained a mild traumatic brain injury (TBI) featured insight by Hollis Bell, MD, attending physician, Brain Innovation Center.
News
Intermittent Hypoxia Initiated Motor Plasticity in Individuals With Multiple Sclerosis
This study aims to understand the mechanisms of a novel intervention involving breathing short durations of low levels of oxygen for persons with multiple sclerosis (MS).
Age Range
18 - 75
Clinical Trial
2023 Awardee: Brooke Dexheimer, PhD, OTD, OTR/L
Brooke Dexheimer's project: a novel method of quantifying lateralized fine motor impairment in Parkinson’s Disease
Page
Understanding how Powered Componentry Impacts Prosthetic Gait with a Transfemoral Prosthesis
The objective of this study is to understand how using a new powered prosthetic knee and/or ankle affects how people walk with a prosthesis.
Age Range
18-95
Clinical Trial
Biofeedback with Wearable Sensors to Facilitate Neuroplasticity in Spinal Cord Injury
To determine if playing games with muscle activity feedback can help people with spinal cord injuries get better at using their arms and hands.
Age Range
Participants must be 18 years or older
Clinical Trial
A Randomized, Double-Blind, Placebo-Controlled Phase 1b/2a Study of NVG-291 in Spinal Cord Injury Subjects
This study is examining how the study drug, NVG-291, affects nerve connections in the spinal cord and whether it is safe and tolerable to use.
Clinical Trial